An Open Label Extension Trial of Eculizumab in Relapsing NMO Patients
Completed · Phase 3
Conditions studied: Neuromyelitis Optica, Neuromyelitis Optica Spectrum Disorder
In brief
The purpose of this study is to determine whether eculizumab long-term use is safe and effective in patients with relapsing NMO.
Key facts
- Study ID
- NCT02003144
- Run by
- Alexion Pharmaceuticals, Inc.
- People needed
- 119
- Starts
- 2015-01-12
- Expected to finish
- 2021-07-12
- Last updated by the study team
- 2022-08-23
Who can join
Age: 18 and older. Sex: any. Healthy volunteers: not accepted.
Where it is running
- The Research Center of Southern California — Oceanside, California, United States
- Georgetown University Hospital — Washington D.C., District of Columbia, United States
- University of Miami McKnight Brain Institute — Miami, Florida, United States
- Neurological Services of Orlando — Orlando, Florida, United States
- Allied Physicians Inc. of Fort Wayne — Fort Wayne, Indiana, United States
- University of Kansas Medical Center — Kansas City, Kansas, United States
- Baptist Health Lexington — Nicholasville, Kentucky, United States
- Johns Hopkins University Medical Center — Baltimore, Maryland, United States
- Mayo Clinic - Rochester — Rochester, Minnesota, United States
- Washington University School of Medicine — St Louis, Missouri, United States
- Multiple Sclerosis Comprehensive Care Center NYU Langone Medical Center — New York, New York, United States
- Mount Sinai School of Medicine — New York, New York, United States
- Ohio Health Reserach Institute — Columbus, Ohio, United States
- University of Pennsylvania School of Medicine — Philadelphia, Pennsylvania, United States
- University of Pittsburgh — Pittsburgh, Pennsylvania, United States
- Multiple Sclerosis Treatment Center of Dallas — Dallas, Texas, United States
- The University of Texas Health Science — San Antonio, Texas, United States
- University of Utah — Salt Lake City, Utah, United States
- Hospital Universitario Austral — Pilar, Buenos Aires, Argentina
- Fundacion Rosarina de Neuro Rehabilitacion — Rosario, Santa Fe Province, Argentina
- Hospital General de Agudos Juan Antonio Fernandez — Ciudad Autonoma, Buenos Aires, Argentina
- Hospital General de Agudos Dr. J. M. Ramos Mejia — Ciudad Autonoma, Buenos Aires,, Argentina
- Brain and Mind Research Institute — Camperdown, New South Wales, Australia
- St. Vincent's Hospital — Fitzroy, Victoria, Australia
- Mayo Clinic Arizona — Scottsdale, Arizona, United States
Full record on ClinicalTrials.gov
Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.